N=1 Collaborative
  • Our Story

  • Our Work

  • Who We Are

  • Resources

    • Workshop Resources
    • FDA Draft Guidances
    • Articles & Media
  • More

    Use tab to navigate through the menu items.

    Who We Are

    Articles & Media 

    Mila

    Milasen

    • ​Patient-Customized Oligonucleotide Therapy for a Rare Genetic Disease, Oct 2019

    • Drug Regulation in the Era of Individualized Therapies, Oct 2019

    News Coverage:

    • Science

    • STAT

    • MIT Tech Review

    Oligonucleotide Therapeutics Society

    Oligonucleotide Therapeutics Society

    • ​​OTS Rare Disease N-of-1+ Briefing Document, Jan 2020

    Afinersen

    Afinersen

    • Suppression of mutant C9orf72 expression by a potent mixed backbone antisense oligonucleotide, Dec 2021

    News Coverage:

    • Nature Medicine

    Jacifusen

    Jacifusen

    • Antisense oligonucleotide silencing of FUS expression as a therapeutic approach in amyotrophic lateral sclerosis, Jan 2022

    News Coverage:

    • STAT

    dsc0097-1-web-2.webp

    Atipeksen ​

    News Coverage:

    • MIT Tech Review

    Biotech and Pharma.jpeg

    Join Our List

    Relationship
    Area(s) of Interest

    Thanks for submitting!

    N=1 Collaborative

    Contact Us

    info@n1collaborative.org

    ©2022 by N=1 Collaborative

    Site By: Finfrock Marketing